This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Covid-19
Large study confirms safety of Covid-19 mRNA vaccine in under fives
Read more
Metformin use linked to lower risk of long Covid
Read more
Could supplementing with vitamin D reduce the risk of long Covid?
Read more
Covid-19 global health emergency over, declares WHO
Read more
Notable signs of recovery from Covid-19, says WHO
Read more
Combining fluvoxamine and inhaled budesonide reduces disease progression in COVID
Read more
Nirmatrelvir treatment reduces the risk of Post-COVID-19 condition
Read more
Prior COVID-19 infection provides similar protection as two doses of mRNA vaccine
Read more
EMA refuses lagevrio marketing authorisation for treatment of COVID
Read more
COVID-19 vaccine effectiveness highlights possible need to continue preventative measures
Read more
JCVI advises on next round of Covid booster vaccinations
Read more
Is heart failure risk increased following COVID-19 infection?
Read more
Remdesivir treatment improves biomarkers associated with severe COVID-19
Read more
Anti-CD20 therapy increases complication risk in COVID-19 for blood cancer patients
Read more
Screening-based predictive tools for COVID-19 in ED inferior to PCR test
Read more
Molnupiravir treatment fails to reduce adverse outcomes among high-risk vaccinated patients
Read more
Favipiravir shortens recovery time only for younger hospitalised COVID-19 patients
Read more
Page 1 of 27
1
2
3
4
5
...
10
20
...
»
Last »
Popular articles
Third of patients in favour of AI-supported consultations and clinical documents, study finds
18 April, 2024
Telemedicine strategy post-acute coronary syndrome drives efficiencies and safety, study finds
17 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
x
Search for: